| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.683 | 0.003 | 0.683 | Calcium channel L-type activator | 0.487 0.033 CID_54040250 | ||
| 0.617 | 0.004 | 0.774 | Alpha-N-acetylglucosaminidase inhibitor | 0.774 0.002 CID_54040250 | CID_54040250 | |
| 0.63 | 0.022 | 0.788 | Cyclophilin D inhibitor | 0.788 0.007 CID_54040250 | CID_54040250 | |
| 0.623 | 0.016 | 0.623 | Aldehyde oxidase inhibitor | |||
| 0.59 | 0.002 | 0.59 | Ferrochelatase inhibitor | 0.13 0.047 CID_54040250 | ||
| 0.591 | 0.005 | 0.591 | Peroxidase inhibitor | |||
| 0.578 | 0.014 | 0.578 | 5 Hydroxytryptamine release inhibitor | 0.529 0.024 CID_54040250 | ||
| 0.571 | 0.024 | 0.571 | Antiobesity | 0.316 0.106 CID_54040250 | ||
| 0.54 | 0.021 | 0.54 | 5 Hydroxytryptamine release stimulant | 0.355 0.055 CID_54040250 | ||
| 0.54 | 0.027 | 0.71 | Cholesterol antagonist | 0.71 0.007 CID_54040250 | CID_54040250 | |
| 0.509 | 0.004 | 0.509 | Bronchodilator | |||
| 0.516 | 0.024 | 0.598 | Histamine release inhibitor | 0.598 0.01 CID_54040250 | CID_54040250 | |
| 0.538 | 0.047 | 0.662 | Caspase 9 stimulant | 0.662 0.028 CID_54040250 | CID_54040250 | |
| 0.512 | 0.025 | 0.512 | Vasodilator, peripheral | 0.48 0.032 CID_54040250 | ||
| 0.499 | 0.015 | 0.68 | Hypoglycemic | 0.68 0.005 CID_54040250 | CID_54040250 | |
| 0.503 | 0.031 | 0.503 | Toll-Like receptor 7 agonist | |||
| 0.477 | 0.007 | 0.477 | Calcium channel activator | 0.272 0.122 CID_54040250 | ||
| 0.493 | 0.024 | 0.493 | Spasmolytic | 0.427 0.035 CID_54040250 | ||
| 0.5 | 0.032 | 0.5 | Toll-Like receptor agonist | |||
| 0.476 | 0.033 | 0.476 | GABA C receptor rho-3 antagonist | |||
| 0.476 | 0.048 | 0.681 | Antibacterial | 0.681 0.01 CID_54040250 | CID_54040250 | |
| 0.464 | 0.052 | 0.464 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.424 | 0.021 | 0.424 | Hypolipemic | 0.359 0.033 CID_54040250 | ||
| 0.404 | 0.003 | 0.404 | Phenylalanine 4-hydroxylase inhibitor | 0.074 0.042 CID_54040250 | ||
| 0.412 | 0.012 | 0.412 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.396 | 0.007 | 0.459 | Peptidyltransferase inhibitor | 0.459 0.004 CID_54040250 | CID_54040250 | |
| 0.437 | 0.051 | 0.576 | Immunosuppressant | 0.576 0.016 CID_54040250 | CID_54040250 | |
| 0.399 | 0.019 | 0.537 | Interleukin agonist | 0.537 0.007 CID_54040250 | CID_54040250 | |
| 0.395 | 0.017 | 0.419 | Anesthetic general | 0.419 0.014 CID_54040250 | CID_54040250 | |
| 0.393 | 0.032 | 0.393 | Interleukin antagonist | |||
| 0.363 | 0.004 | 0.55 | Triose-phosphate isomerase inhibitor | 0.55 0.002 CID_54040250 | CID_54040250 | |
| 0.361 | 0.014 | 0.361 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.378 | 0.043 | 0.542 | Vasodilator, coronary | 0.542 0.011 CID_54040250 | CID_54040250 | |
| 0.366 | 0.039 | 0.541 | Interleukin 2 agonist | 0.541 0.005 CID_54040250 | CID_54040250 | |
| 0.33 | 0.004 | 0.33 | Alcohol oxidase inhibitor | 0.069 0.029 CID_54040250 | ||
| 0.351 | 0.025 | 0.394 | Cyclic AMP phosphodiesterase inhibitor | 0.394 0.017 CID_54040250 | CID_54040250 | |
| 0.33 | 0.016 | 0.33 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.284 0.029 CID_54040250 | ||
| 0.321 | 0.008 | 0.321 | Nitric-oxide synthase stimulant | 0.267 0.023 CID_54040250 | ||
| 0.337 | 0.039 | 0.337 | Superoxide dismutase inhibitor | |||
| 0.357 | 0.062 | 0.677 | Antithrombotic | 0.677 0.009 CID_54040250 | CID_54040250 | |
| 0.301 | 0.007 | 0.301 | Adenylate kinase inhibitor | 0.231 0.011 CID_54040250 | ||
| 0.31 | 0.017 | 0.563 | Amylase inhibitor | 0.563 0.004 CID_54040250 | CID_54040250 | |
| 0.297 | 0.01 | 0.472 | UDP-glucose 4-epimerase inhibitor | 0.472 0.003 CID_54040250 | CID_54040250 | |
| 0.306 | 0.021 | 0.386 | Melanin inhibitor | 0.386 0.013 CID_54040250 | CID_54040250 | |
| 0.334 | 0.051 | 0.334 | Sodium/bile acid cotransporter inhibitor | 0.2 0.188 CID_54040250 | ||
| 0.292 | 0.01 | 0.292 | GABA C receptor agonist | |||
| 0.292 | 0.012 | 0.292 | Succinate dehydrogenase inhibitor | 0.157 0.1 CID_54040250 | ||
| 0.281 | 0.005 | 0.281 | Electron transport complex I inhibitor | |||
| 0.286 | 0.011 | 0.407 | Cell wall synthesis inhibitor | 0.407 0.006 CID_54040250 | CID_54040250 | |
| 0.268 | 0.005 | 0.269 | Photosensitizer | 0.269 0.005 CID_54040250 | CID_54040250 | |
| 0.275 | 0.015 | 0.275 | Antiadrenergic | |||
| 0.272 | 0.015 | 0.272 | Adrenaline antagonist | |||
| 0.299 | 0.043 | 0.299 | Psychostimulant | 0.22 0.07 CID_54040250 | ||
| 0.274 | 0.021 | 0.312 | Protein kinase stimulant | 0.312 0.015 CID_54040250 | CID_54040250 | |
| 0.295 | 0.045 | 0.426 | DNA synthesis inhibitor | 0.426 0.019 CID_54040250 | CID_54040250 | |
| 0.249 | 0.004 | 0.249 | Glutamate decarboxylase inhibitor | 0.072 0.052 CID_54040250 | ||
| 0.26 | 0.019 | 0.26 | NADPH oxidase inhibitor | 0.213 0.03 CID_54040250 | ||
| 0.269 | 0.029 | 0.269 | Neurotrophic factor enhancer | 0.236 0.047 CID_54040250 | ||
| 0.265 | 0.027 | 0.265 | Insulin sensitizer | 0.207 0.066 CID_54040250 | ||
| 0.243 | 0.006 | 0.243 | MAP3K9 inhibitor | |||
| 0.243 | 0.01 | 0.303 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.303 0.006 CID_54040250 | CID_54040250 | |
| 0.233 | 0.005 | 0.233 | Adenylate cyclase stimulant | 0.177 0.028 CID_54040250 | ||
| 0.235 | 0.009 | 0.235 | Porphobilinogen synthase inhibitor | |||
| 0.233 | 0.006 | 0.233 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.232 | 0.011 | 0.452 | Cyclooxygenase 3 inhibitor | 0.452 0.004 CID_54040250 | CID_54040250 | |
| 0.239 | 0.022 | 0.239 | Anesthetic local | |||
| 0.236 | 0.02 | 0.236 | Cholesterol synthesis inhibitor | 0.153 0.043 CID_54040250 | ||
| 0.272 | 0.056 | 0.272 | Gastrin inhibitor | 0.231 0.104 CID_54040250 | ||
| 0.21 | 0.009 | 0.21 | Creatine kinase inhibitor | |||
| 0.201 | 0.006 | 0.201 | Toll-Like receptor 3 antagonist | |||
| 0.206 | 0.012 | 0.206 | Mucolytic | 0.195 0.014 CID_54040250 | ||
| 0.293 | 0.098 | 0.608 | Transcription factor NF kappa B inhibitor | 0.608 0.03 CID_54040250 | CID_54040250 | |
| 0.202 | 0.009 | 0.202 | Sphingomyelinase inhibitor | 0.152 0.024 CID_54040250 | ||
| 0.304 | 0.112 | 0.304 | Calpain 2 inhibitor | |||
| 0.196 | 0.004 | 0.196 | Ca2+-transporting ATPase inhibitor | 0.196 0.004 CID_54040250 | ||
| 0.225 | 0.033 | 0.43 | Interferon gamma antagonist | 0.43 0.009 CID_54040250 | CID_54040250 | |
| 0.244 | 0.053 | 0.244 | RNA-directed DNA polymerase inhibitor | 0.211 0.085 CID_54040250 | ||
| 0.213 | 0.022 | 0.213 | Arachidonic acid antagonist | 0.162 0.074 CID_54040250 | ||
| 0.197 | 0.007 | 0.197 | Adrenaline agonist | |||
| 0.209 | 0.02 | 0.212 | Interleukin 4 antagonist | 0.212 0.019 CID_54040250 | CID_54040250 | |
| 0.195 | 0.007 | 0.195 | Somatostatin 1 agonist | 0.072 0.062 CID_54040250 | ||
| 0.202 | 0.015 | 0.202 | Catalase inhibitor | |||
| 0.195 | 0.011 | 0.479 | NADH dehydrogenase inhibitor | 0.479 0.003 CID_54040250 | CID_54040250 | |
| 0.268 | 0.085 | 0.268 | Hypoxia-inducible factor 1 alpha inhibitor | 0.243 0.107 CID_54040250 | ||
| 0.186 | 0.005 | 0.186 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.201 | 0.02 | 0.392 | Expectorant | 0.392 0.005 CID_54040250 | CID_54040250 | |
| 0.27 | 0.089 | 0.518 | Immunostimulant | 0.518 0.027 CID_54040250 | CID_54040250 | |
| 0.194 | 0.014 | 0.194 | GABA C receptor antagonist | |||
| 0.198 | 0.019 | 0.198 | Nav1.4 sodium channel blocker | |||
| 0.204 | 0.027 | 0.204 | GABA C receptor rho-2 antagonist | |||
| 0.183 | 0.007 | 0.183 | Biliverdin reductase inhibitor | 0.114 0.015 CID_54040250 | ||
| 0.347 | 0.175 | 0.841 | Antiinflammatory | 0.841 0.01 CID_54040250 | CID_54040250 | |
| 0.178 | 0.008 | 0.178 | Prostaglandin EP2 antagonist | 0.056 0.045 CID_54040250 | ||
| 0.173 | 0.008 | 0.173 | Interleukin 5 antagonist | 0.094 0.048 CID_54040250 | ||
| 0.191 | 0.027 | 0.191 | Cystathionine beta-synthase inhibitor | 0.14 0.046 CID_54040250 | ||
| 0.171 | 0.009 | 0.171 | Anabolic | 0.122 0.038 CID_54040250 | ||
| 0.189 | 0.028 | 0.189 | Adenylate cyclase inhibitor | 0.131 0.059 CID_54040250 | ||
| 0.245 | 0.083 | 0.411 | DNA damaging | 0.411 0.026 CID_54040250 | CID_54040250 | |
| 0.202 | 0.043 | 0.202 | Diuretic | 0.186 0.05 CID_54040250 | ||
| 0.178 | 0.02 | 0.178 | Pregnane X receptor agonist | |||
| 0.164 | 0.007 | 0.261 | Glutamate release inhibitor | 0.261 0.004 CID_54040250 | CID_54040250 | |
| 0.171 | 0.014 | 0.171 | GABA C receptor rho-1 antagonist | |||
| 0.199 | 0.043 | 0.199 | Phospholipase A2 inhibitor | 0.144 0.081 CID_54040250 | ||
| 0.232 | 0.077 | 0.552 | Free radical scavenger | 0.552 0.012 CID_54040250 | CID_54040250 | |
| 0.198 | 0.043 | 0.198 | Acetylcholine M1 receptor antagonist | |||
| 0.206 | 0.053 | 0.206 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.17 | 0.018 | 0.17 | Calcium antagonist | |||
| 0.232 | 0.081 | 0.385 | Platelet antagonist | 0.385 0.03 CID_54040250 | CID_54040250 | |
| 0.229 | 0.078 | 0.229 | Neuropeptide Y2 antagonist | |||
| 0.188 | 0.037 | 0.226 | Mannose-6-phosphate isomerase inhibitor | 0.226 0.019 CID_54040250 | CID_54040250 | |
| 0.162 | 0.016 | 0.286 | Phosphofructokinase-1 inhibitor | 0.286 0.006 CID_54040250 | CID_54040250 | |
| 0.174 | 0.028 | 0.174 | Aminopeptidase B inhibitor | |||
| 0.159 | 0.014 | 0.159 | Glutamate dehydrogenase inhibitor | 0.107 0.027 CID_54040250 | ||
| 0.192 | 0.05 | 0.192 | Phospholipase C inhibitor | 0.176 0.066 CID_54040250 | ||
| 0.167 | 0.025 | 0.167 | Carbonic anhydrase XV inhibitor | |||
| 0.148 | 0.009 | 0.148 | Acyl-CoA dehydrogenase inhibitor | 0.073 0.025 CID_54040250 | ||
| 0.142 | 0.004 | 0.142 | Aconitate hydratase inhibitor | |||
| 0.157 | 0.02 | 0.157 | Urease inhibitor | |||
| 0.241 | 0.105 | 0.241 | Insulysin inhibitor | |||
| 0.151 | 0.014 | 0.151 | Keratolytic | |||
| 0.166 | 0.03 | 0.228 | Microtubule formation inhibitor | 0.228 0.014 CID_54040250 | CID_54040250 | |
| 0.158 | 0.026 | 0.158 | Carbonic anhydrase III inhibitor | 0.102 0.059 CID_54040250 | ||
| 0.238 | 0.108 | 0.238 | Lipoxygenase inhibitor | |||
| 0.143 | 0.012 | 0.143 | Argininosuccinate synthase inhibitor | 0.088 0.022 CID_54040250 | ||
| 0.15 | 0.019 | 0.15 | Electrolyte absorption antagonist | |||
| 0.229 | 0.098 | 0.229 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.15 | 0.023 | 0.15 | Androgen antagonist | |||
| 0.141 | 0.014 | 0.141 | Aminopeptidase I inhibitor | |||
| 0.135 | 0.009 | 0.135 | Purinergic P2X1 antagonist | 0.079 0.026 CID_54040250 | ||
| 0.137 | 0.011 | 0.137 | mTOR complex 2 inhibitor | |||
| 0.163 | 0.037 | 0.163 | Antibacterial (Helicobacter pylori) | |||
| 0.215 | 0.09 | 0.271 | Antiamyloidogenic | 0.271 0.062 CID_54040250 | CID_54040250 | |
| 0.139 | 0.016 | 0.139 | Glutamate (mGluR7) agonist | |||
| 0.163 | 0.04 | 0.428 | Alkylator | 0.428 0.006 CID_54040250 | CID_54040250 | |
| 0.18 | 0.058 | 0.244 | ATPase inhibitor | 0.244 0.015 CID_54040250 | CID_54040250 | |
| 0.146 | 0.024 | 0.146 | DOPA decarboxylase inhibitor | |||
| 0.156 | 0.034 | 0.156 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.148 | 0.028 | 0.148 | Gastric antisecretory | |||
| 0.134 | 0.013 | 0.134 | Carbamoyl phosphate synthetase inhibitor | 0.07 0.035 CID_54040250 | ||
| 0.133 | 0.013 | 0.133 | Leukotriene antagonist | 0.099 0.022 CID_54040250 | ||
| 0.214 | 0.094 | 0.39 | Vasodilator | 0.39 0.025 CID_54040250 | CID_54040250 | |
| 0.142 | 0.022 | 0.142 | Cathepsin G inhibitor | |||
| 0.124 | 0.005 | 0.124 | Potassium channel Kv1.3 blocker | |||
| 0.127 | 0.009 | 0.127 | Beta 3 adrenoreceptor antagonist | |||
| 0.219 | 0.102 | 0.619 | Antioxidant | 0.619 0.01 CID_54040250 | CID_54040250 | |
| 0.216 | 0.098 | 0.216 | Calpain inhibitor | |||
| 0.138 | 0.021 | 0.138 | Histidine decarboxylase inhibitor | |||
| 0.127 | 0.01 | 0.138 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.138 0.009 CID_54040250 | CID_54040250 | |
| 0.193 | 0.077 | 0.303 | Non-steroidal antiinflammatory agent | 0.303 0.027 CID_54040250 | CID_54040250 | |
| 0.121 | 0.006 | 0.132 | Factor IXa inhibitor | 0.132 0.005 CID_54040250 | CID_54040250 | |
| 0.139 | 0.024 | 0.15 | Acetylcholine release stimulant | 0.15 0.016 CID_54040250 | CID_54040250 | |
| 0.148 | 0.033 | 0.148 | Alpha 2c adrenoreceptor antagonist | |||
| 0.132 | 0.018 | 0.132 | Ornithine decarboxylase inhibitor | 0.086 0.06 CID_54040250 | ||
| 0.132 | 0.019 | 0.132 | Alpha adrenoreceptor agonist | |||
| 0.122 | 0.01 | 0.122 | Beta adrenoreceptor antagonist | |||
| 0.115 | 0.003 | 0.115 | Calcium-sensing receptor antagonist | |||
| 0.123 | 0.011 | 0.144 | Neuraminidase (influenza) inhibitor | 0.144 0.008 CID_54040250 | CID_54040250 | |
| 0.119 | 0.008 | 0.119 | GABA B receptor agonist | |||
| 0.116 | 0.006 | 0.116 | Glutamate (mGluR6) antagonist | 0.069 0.041 CID_54040250 | ||
| 0.153 | 0.044 | 0.153 | Cathepsin H inhibitor | |||
| 0.155 | 0.045 | 0.337 | Monophenol monooxygenase inhibitor | 0.337 0.014 CID_54040250 | CID_54040250 | |
| 0.114 | 0.005 | 0.114 | Exportin-1 inhibitor | |||
| 0.116 | 0.008 | 0.127 | Leukotriene B4 antagonist | 0.127 0.006 CID_54040250 | CID_54040250 | |
| 0.112 | 0.005 | 0.233 | Alpha-mannosidase inhibitor | 0.233 0.003 CID_54040250 | CID_54040250 | |
| 0.139 | 0.033 | 0.139 | Transcription factor STAT6 inhibitor | |||
| 0.11 | 0.005 | 0.239 | Mannosidase inhibitor | 0.239 0.003 CID_54040250 | CID_54040250 | |
| 0.151 | 0.047 | 0.151 | Aldehyde dehydrogenase inhibitor | 0.134 0.058 CID_54040250 | ||
| 0.116 | 0.012 | 0.116 | Estrogen-related receptor beta agonist | |||
| 0.108 | 0.004 | 0.108 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.14 | 0.038 | 0.14 | TRPA1 agonist | |||
| 0.11 | 0.008 | 0.11 | Beta 1 adrenoreceptor antagonist | |||
| 0.105 | 0.004 | 0.105 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.132 | 0.031 | 0.132 | Prolactin inhibitor | |||
| 0.118 | 0.017 | 0.118 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.115 | 0.014 | 0.115 | Glycine receptor agonist | 0.114 0.014 CID_54040250 | ||
| 0.147 | 0.048 | 0.147 | Proteasome inhibitor | |||
| 0.122 | 0.023 | 0.15 | Phosphodiesterase 6D inhibitor | 0.15 0.009 CID_54040250 | CID_54040250 | |
| 0.111 | 0.012 | 0.111 | Alpha 2 adrenoreceptor agonist | |||
| 0.106 | 0.007 | 0.106 | Glucosylceramidase inhibitor | 0.075 0.018 CID_54040250 | ||
| 0.267 | 0.169 | 0.383 | Analgesic | 0.383 0.092 CID_54040250 | CID_54040250 | |
| 0.105 | 0.008 | 0.105 | Oleamide hydrolase inhibitor | |||
| 0.116 | 0.019 | 0.14 | Interferon agonist | 0.14 0.012 CID_54040250 | CID_54040250 | |
| 0.188 | 0.092 | 0.188 | Anticonvulsant | |||
| 0.118 | 0.022 | 0.118 | Bile acid receptor antagonist | 0.098 0.054 CID_54040250 | ||
| 0.144 | 0.048 | 0.144 | Acetylcholine muscarinic antagonist | |||
| 0.102 | 0.006 | 0.102 | Potassium channel (Inward rectifier) blocker | |||
| 0.15 | 0.054 | 0.15 | Nav1.6 sodium channel blocker | |||
| 0.114 | 0.019 | 0.114 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.111 | 0.016 | 0.111 | Carbonic anhydrase stimulant | |||
| 0.114 | 0.02 | 0.127 | Na+ K+ transporting ATPase inhibitor | 0.127 0.013 CID_54040250 | CID_54040250 | |
| 0.098 | 0.004 | 0.098 | Alpha 1d adrenoreceptor agonist | |||
| 0.148 | 0.054 | 0.148 | Toll-Like receptor 2 antagonist | |||
| 0.107 | 0.013 | 0.114 | Neuraminidase inhibitor | 0.114 0.011 CID_54040250 | CID_54040250 | |
| 0.157 | 0.063 | 0.157 | Thiol protease inhibitor | |||
| 0.097 | 0.004 | 0.097 | Pregnane X receptor antagonist | 0.063 0.024 CID_54040250 | ||
| 0.213 | 0.121 | 0.213 | Transcription factor STAT inhibitor | |||
| 0.117 | 0.025 | 0.117 | Bromodomain-containing protein 2 inhibitor | |||
| 0.151 | 0.06 | 0.151 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.095 | 0.008 | 0.095 | Beta 2 adrenoreceptor antagonist | |||
| 0.155 | 0.068 | 0.155 | CF transmembrane conductance regulator agonist | 0.155 0.068 CID_54040250 | ||
| 0.092 | 0.005 | 0.092 | Prostaglandin agonist | |||
| 0.097 | 0.013 | 0.097 | Glutamate (mGluR7) antagonist | |||
| 0.106 | 0.022 | 0.106 | D-Ala-D-Ala ligase inhibitor | |||
| 0.097 | 0.014 | 0.113 | Interferon inducer | 0.113 0.009 CID_54040250 | CID_54040250 | |
| 0.109 | 0.025 | 0.145 | Glycine receptor antagonist | 0.145 0.009 CID_54040250 | CID_54040250 | |
| 0.086 | 0.005 | 0.086 | Diamine oxidase inhibitor | |||
| 0.084 | 0.003 | 0.084 | Alpha 2a adrenoreceptor agonist | |||
| 0.087 | 0.007 | 0.122 | Glucose-6-phosphate isomerase inhibitor | 0.122 0.003 CID_54040250 | CID_54040250 | |
| 0.13 | 0.05 | 0.13 | Alpha 2b adrenoreceptor antagonist | |||
| 0.143 | 0.064 | 0.143 | Heat shock protein 70 antagonist | 0.143 0.064 CID_54040250 | ||
| 0.096 | 0.017 | 0.096 | NMDA 2C receptor antagonist | |||
| 0.085 | 0.007 | 0.085 | Beta 2 adrenoreceptor agonist | |||
| 0.087 | 0.008 | 0.087 | Somatostatin 1 antagonist | 0.035 0.03 CID_54040250 | ||
| 0.097 | 0.02 | 0.097 | NMDA receptor agonist | |||
| 0.093 | 0.017 | 0.093 | Androgen agonist | |||
| 0.114 | 0.039 | 0.114 | NMDA receptor antagonist | |||
| 0.135 | 0.06 | 0.135 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.18 | 0.107 | 0.18 | Potassium channel blocker | |||
| 0.1 | 0.027 | 0.132 | GABA aminotransferase inhibitor | 0.132 0.012 CID_54040250 | CID_54040250 | |
| 0.134 | 0.062 | 0.134 | Cholinergic antagonist | |||
| 0.082 | 0.01 | 0.082 | Dihydroorotate oxidase inhibitor | |||
| 0.138 | 0.066 | 0.138 | Nav1.2 sodium channel blocker | |||
| 0.093 | 0.022 | 0.093 | Secretase beta inhibitor | |||
| 0.202 | 0.131 | 0.202 | Transcription factor STAT3 inhibitor | |||
| 0.147 | 0.077 | 0.306 | Insulin secretagoues | 0.306 0.012 CID_54040250 | CID_54040250 | |
| 0.091 | 0.022 | 0.091 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.09 | 0.022 | 0.09 | Phospholipase D inhibitor | |||
| 0.076 | 0.007 | 0.076 | Fumarate hydratase inhibitor | 0.046 0.015 CID_54040250 | ||
| 0.092 | 0.024 | 0.092 | Vanilloid 4 agonist | |||
| 0.072 | 0.004 | 0.072 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.106 | 0.039 | 0.106 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.141 | 0.074 | 0.305 | Lipid peroxidase inhibitor | 0.305 0.018 CID_54040250 | CID_54040250 | |
| 0.073 | 0.006 | 0.073 | Membrane dipeptidase inhibitor | |||
| 0.129 | 0.063 | 0.129 | Acetylcholine antagonist | |||
| 0.07 | 0.004 | 0.114 | Sodium/glucose cotransporter 2 inhibitor | 0.114 0.002 CID_54040250 | CID_54040250 | |
| 0.075 | 0.009 | 0.075 | Somatostatin 5 antagonist | |||
| 0.119 | 0.053 | 0.119 | Protein kinase C gamma inhibitor | |||
| 0.071 | 0.005 | 0.071 | Glucagon receptor antagonist | |||
| 0.131 | 0.065 | 0.131 | Vanilloid 1 agonist | 0.131 0.064 CID_54040250 | ||
| 0.106 | 0.041 | 0.106 | Phosphodiesterase IV inhibitor | |||
| 0.093 | 0.027 | 0.093 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.155 | 0.089 | 0.155 | Antipruritic | 0.141 0.106 CID_54040250 | ||
| 0.081 | 0.016 | 0.081 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.086 | 0.022 | 0.086 | Acetylcholine M5 receptor antagonist | |||
| 0.136 | 0.072 | 0.136 | Farnesoid X receptor antagonist | |||
| 0.146 | 0.083 | 0.221 | Hexokinase inhibitor | 0.221 0.025 CID_54040250 | CID_54040250 | |
| 0.191 | 0.128 | 0.191 | Cardiotonic | |||
| 0.093 | 0.032 | 0.093 | Estrogen receptor alpha antagonist | |||
| 0.086 | 0.026 | 0.086 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.153 | 0.093 | 0.153 | Neurotensin receptor agonist | |||
| 0.068 | 0.008 | 0.103 | Cytokine production stimulant | 0.103 0.004 CID_54040250 | CID_54040250 | |
| 0.077 | 0.017 | 0.077 | Sphingosine kinase 2 inhibitor | |||
| 0.077 | 0.018 | 0.128 | Phosphorylase inhibitor | 0.128 0.009 CID_54040250 | CID_54040250 | |
| 0.063 | 0.004 | 0.063 | Ceramide glucosyltransferase inhibitor | 0.054 0.005 CID_54040250 | ||
| 0.08 | 0.021 | 0.08 | Ornithine carbamoyltransferase inhibitor | 0.046 0.043 CID_54040250 | ||
| 0.063 | 0.005 | 0.063 | Heme oxygenase inhibitor | |||
| 0.124 | 0.066 | 0.124 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.124 | 0.066 | 0.245 | DNA repair enzyme inhibitor | 0.245 0.005 CID_54040250 | CID_54040250 | |
| 0.063 | 0.005 | 0.063 | Prostaglandin E2 agonist | |||
| 0.093 | 0.037 | 0.093 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.06 | 0.005 | 0.06 | Purinergic P2Y14 antagonist | |||
| 0.062 | 0.007 | 0.062 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.074 | 0.019 | 0.074 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.058 | 0.003 | 0.058 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.105 | 0.05 | 0.105 | MAP kinase kinase 1 inhibitor | |||
| 0.063 | 0.009 | 0.063 | Guanylate cyclase inhibitor | 0.063 0.009 CID_54040250 | ||
| 0.071 | 0.017 | 0.071 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.059 | 0.006 | 0.059 | Liver X receptor beta antagonist | |||
| 0.075 | 0.022 | 0.075 | NMDA 2A receptor antagonist | |||
| 0.061 | 0.008 | 0.061 | Beta adrenoreceptor agonist | |||
| 0.079 | 0.026 | 0.079 | Acetylcholine M3 receptor antagonist | |||
| 0.059 | 0.007 | 0.059 | Kainate receptor agonist | |||
| 0.063 | 0.011 | 0.063 | Dopamine D5 agonist | |||
| 0.148 | 0.096 | 0.458 | Nitric oxide antagonist | 0.458 0.019 CID_54040250 | CID_54040250 | |
| 0.094 | 0.043 | 0.094 | Glutathione S-transferase inhibitor | |||
| 0.062 | 0.011 | 0.062 | Somatostatin 2 antagonist | |||
| 0.055 | 0.004 | 0.055 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.066 | 0.015 | 0.066 | NMDA receptor subunit 3A antagonist | |||
| 0.056 | 0.006 | 0.056 | Prostaglandin D2 agonist | |||
| 0.085 | 0.034 | 0.085 | MAP kinase kinase 7 inhibitor | |||
| 0.108 | 0.059 | 0.306 | Beta glucuronidase inhibitor | 0.306 0.006 CID_54040250 | CID_54040250 | |
| 0.054 | 0.005 | 0.104 | Sodium/glucose cotransporter inhibitor | 0.104 0.003 CID_54040250 | CID_54040250 | |
| 0.053 | 0.004 | 0.053 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.052 | 0.004 | 0.052 | Nicotinic acid receptor 2 antagonist | |||
| 0.156 | 0.108 | 0.156 | P-glycoprotein inhibitor | 0.141 0.131 CID_54040250 | ||
| 0.053 | 0.005 | 0.053 | Cholesterol ester transfer protein antagonist | |||
| 0.064 | 0.017 | 0.064 | Immunoglobulin Fc receptor antagonist | |||
| 0.05 | 0.003 | 0.05 | 1,3-Beta-glucan synthase inhibitor | 0.039 0.004 CID_54040250 | ||
| 0.087 | 0.039 | 0.087 | NMDA 2 receptor antagonist | |||
| 0.052 | 0.005 | 0.052 | Prostaglandin EP4 agonist | |||
| 0.106 | 0.06 | 0.196 | Toll-Like receptor 4 antagonist | 0.196 0.007 CID_54040250 | CID_54040250 | |
| 0.056 | 0.01 | 0.056 | Angiotensin AT1 receptor antagonist | |||
| 0.06 | 0.014 | 0.06 | Retinoid X receptor agonist | |||
| 0.092 | 0.045 | 0.092 | Carbonic anhydrase VI inhibitor | |||
| 0.128 | 0.083 | 0.128 | Neurotrophic factor | |||
| 0.09 | 0.045 | 0.09 | Glutamate receptor agonist | |||
| 0.052 | 0.006 | 0.052 | Leukotriene B4 receptor 1 antagonist | 0.052 0.006 CID_54040250 | ||
| 0.089 | 0.044 | 0.089 | Carbonic anhydrase XIII inhibitor | 0.076 0.053 CID_54040250 | ||
| 0.119 | 0.075 | 0.119 | Nav1.3 sodium channel blocker | |||
| 0.08 | 0.035 | 0.08 | Potassium channel (Tandem pore domain) blocker | |||
| 0.15 | 0.105 | 0.15 | Lipocortins synthesis antagonist | 0.145 0.113 CID_54040250 | ||
| 0.071 | 0.027 | 0.071 | Calcium channel P-type blocker | |||
| 0.067 | 0.023 | 0.067 | Thromboxane A2 antagonist | |||
| 0.06 | 0.017 | 0.06 | Adenylate cyclase 1 inhibitor | |||
| 0.052 | 0.01 | 0.052 | Glutamate (mGluR8) agonist | |||
| 0.048 | 0.006 | 0.048 | Prostaglandin EP2 agonist | |||
| 0.054 | 0.013 | 0.054 | Phosphoglycerate kinase inhibitor | |||
| 0.057 | 0.015 | 0.057 | Urate transporter 1 inhibitor | |||
| 0.05 | 0.008 | 0.051 | Uridine phosphorylase inhibitor | 0.051 0.008 CID_54040250 | CID_54040250 | |
| 0.068 | 0.027 | 0.068 | Thromboxane antagonist | |||
| 0.153 | 0.112 | 0.153 | Pyruvate kinase inhibitor | |||
| 0.074 | 0.034 | 0.074 | Potassium channel (ATP-sensitive) blocker | |||
| 0.079 | 0.039 | 0.079 | Amidase inhibitor | |||
| 0.043 | 0.003 | 0.043 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.043 | 0.004 | 0.043 | Alpha 2b adrenoreceptor agonist | |||
| 0.053 | 0.013 | 0.053 | Vascular adhesion protein 1 inhibitor | |||
| 0.057 | 0.017 | 0.057 | Growth hormone release inhibitor | |||
| 0.046 | 0.008 | 0.046 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.063 | 0.024 | 0.063 | Thromboxane synthase inhibitor | |||
| 0.056 | 0.017 | 0.056 | Geranyltranstransferase inhibitor | |||
| 0.096 | 0.057 | 0.096 | Alcohol dehydrogenase inhibitor | 0.091 0.063 CID_54040250 | ||
| 0.062 | 0.024 | 0.062 | Leukotriene C antagonist | |||
| 0.055 | 0.017 | 0.197 | Neurokinin 1 antagonist | 0.197 0.004 CID_54040250 | CID_54040250 | |
| 0.047 | 0.009 | 0.047 | Angiotensin II receptor antagonist | |||
| 0.091 | 0.054 | 0.091 | Alpha 2 adrenoreceptor antagonist | |||
| 0.054 | 0.017 | 0.054 | 5-Alpha-reductase inhibitor | |||
| 0.111 | 0.074 | 0.111 | Caspase 3 inhibitor | |||
| 0.076 | 0.04 | 0.076 | Leukotriene synthesis inhibitor | |||
| 0.084 | 0.047 | 0.084 | Macrophage migration inhibitory factor inhibitor | |||
| 0.051 | 0.015 | 0.051 | GABA uptake inhibitor | |||
| 0.053 | 0.017 | 0.053 | Liver X receptor alpha agonist | |||
| 0.042 | 0.006 | 0.042 | Purinergic P2Y15 antagonist | |||
| 0.066 | 0.03 | 0.066 | Sphingosine kinase inhibitor | |||
| 0.054 | 0.019 | 0.054 | Erythropoietin receptor agonist | |||
| 0.127 | 0.093 | 0.127 | Cytidine deaminase inhibitor | |||
| 0.042 | 0.008 | 0.042 | Somatostatin 4 antagonist | 0.022 0.019 CID_54040250 | ||
| 0.07 | 0.036 | 0.07 | NMDA receptor glycine site agonist | |||
| 0.052 | 0.019 | 0.052 | Glutamate (mGluR1a) antagonist | |||
| 0.05 | 0.018 | 0.05 | Progesterone antagonist | |||
| 0.058 | 0.026 | 0.058 | Glycine transporter inhibitor | |||
| 0.07 | 0.038 | 0.07 | Aryl hydrocarbon receptor antagonist | |||
| 0.037 | 0.005 | 0.06 | Leukotriene B4 receptor 2 antagonist | 0.06 0.004 CID_54040250 | CID_54040250 | |
| 0.056 | 0.024 | 0.056 | Adenosine deaminase inhibitor | 0.053 0.028 CID_54040250 | ||
| 0.054 | 0.023 | 0.054 | Dopamine beta hydroxylase inhibitor | |||
| 0.052 | 0.021 | 0.067 | Neuraminidase (Influenza A) inhibitor | 0.067 0.009 CID_54040250 | CID_54040250 | |
| 0.048 | 0.017 | 0.048 | TRPM8 blocker | |||
| 0.095 | 0.064 | 0.095 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.047 | 0.016 | 0.047 | Nicotinic acid receptor agonist | |||
| 0.063 | 0.033 | 0.063 | Maillard reaction inhibitor | |||
| 0.043 | 0.013 | 0.043 | Liver X receptor beta agonist | |||
| 0.037 | 0.007 | 0.037 | Estrogen-related receptor gamma antagonist | |||
| 0.09 | 0.061 | 0.09 | Polo-like kinase-1 inhibitor | |||
| 0.074 | 0.046 | 0.074 | Benzodiazepine agonist | |||
| 0.052 | 0.024 | 0.052 | NMDA receptor subunit 3B antagonist | |||
| 0.153 | 0.126 | 0.153 | Focal adhesion kinase 2 inhibitor | |||
| 0.044 | 0.017 | 0.044 | CF transmembrane conductance regulator antagonist | |||
| 0.032 | 0.005 | 0.043 | Ileal bile acid transport inhibitor | 0.043 0.004 CID_54040250 | CID_54040250 | |
| 0.054 | 0.027 | 0.054 | Squalene epoxidase inhibitor | 0.047 0.04 CID_54040250 | ||
| 0.077 | 0.051 | 0.077 | CYP2A6 inhibitor | |||
| 0.031 | 0.004 | 0.031 | Neuraminidase (Influenza B) inhibitor | |||
| 0.069 | 0.042 | 0.069 | MDM2 inhibitor | |||
| 0.037 | 0.011 | 0.037 | Liver X receptor alpha antagonist | |||
| 0.031 | 0.005 | 0.031 | Alpha 2c adrenoreceptor agonist | |||
| 0.052 | 0.026 | 0.052 | Cholesterol esterase inhibitor | |||
| 0.082 | 0.057 | 0.082 | CC chemokine 5 receptor agonist | |||
| 0.033 | 0.008 | 0.033 | Prostaglandin F2 alpha agonist | |||
| 0.046 | 0.022 | 0.046 | Thymidine kinase inhibitor | |||
| 0.061 | 0.036 | 0.061 | Botulinum neurotoxin type A inhibitor | |||
| 0.034 | 0.009 | 0.034 | Thyroid hormone agonist | |||
| 0.054 | 0.029 | 0.054 | Proto-oncogene tyrosine-protein kinase Met inhibitor | |||
| 0.061 | 0.037 | 0.061 | Dopamine uptake inhibitor | |||
| 0.032 | 0.008 | 0.032 | Acid ceramidase inhibitor | |||
| 0.053 | 0.029 | 0.053 | Topoisomerase II beta inhibitor | |||
| 0.05 | 0.026 | 0.05 | Complement C3a chemotactic receptor antagonist | |||
| 0.053 | 0.03 | 0.053 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.077 | 0.053 | 0.077 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.062 | 0.038 | 0.062 | Cathepsin E inhibitor | |||
| 0.069 | 0.045 | 0.069 | Phosphodiesterase 4B inhibitor | |||
| 0.032 | 0.008 | 0.044 | Vanilloid 2 agonist | 0.044 0.004 CID_54040250 | CID_54040250 | |
| 0.097 | 0.074 | 0.159 | Mediator release inhibitor | 0.159 0.025 CID_54040250 | CID_54040250 | |
| 0.06 | 0.037 | 0.06 | Ryanodine receptor antagonist | |||
| 0.027 | 0.004 | 0.047 | Antibiotic Anthracycline-like | 0.047 0.002 CID_54040250 | CID_54040250 | |
| 0.07 | 0.049 | 0.07 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.058 | 0.037 | 0.058 | Carbonic anhydrase VB inhibitor | |||
| 0.037 | 0.016 | 0.037 | Liver X receptor antagonist | |||
| 0.081 | 0.06 | 0.081 | Inducible nitric-oxide synthase inhibitor | |||
| 0.031 | 0.01 | 0.031 | Hedgehog signaling activator | |||
| 0.045 | 0.025 | 0.045 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.043 | 0.023 | 0.174 | Substance P antagonist | 0.174 0.004 CID_54040250 | CID_54040250 | |
| 0.036 | 0.015 | 0.036 | Glutamate (mGluR3) agonist | |||
| 0.052 | 0.032 | 0.052 | Potassium channel (Inward rectifier) activator | |||
| 0.04 | 0.02 | 0.04 | Retinoid X alpha receptor agonist | |||
| 0.053 | 0.033 | 0.053 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.033 | 0.013 | 0.033 | Prostaglandin EP4 antagonist | |||
| 0.052 | 0.032 | 0.162 | Neurokinin antagonist | 0.162 0.005 CID_54040250 | CID_54040250 | |
| 0.04 | 0.021 | 0.04 | Glutamate (mGluR3) antagonist | |||
| 0.041 | 0.022 | 0.041 | Leukotriene C4 antagonist | |||
| 0.058 | 0.039 | 0.058 | Alpha 1 adrenoreceptor agonist | |||
| 0.049 | 0.031 | 0.049 | Potassium channel (ATP-sensitive) activator | |||
| 0.086 | 0.067 | 0.086 | Potassium channel activator | |||
| 0.043 | 0.025 | 0.043 | Sphingosine kinase 1 inhibitor | |||
| 0.062 | 0.043 | 0.062 | Acetylcholine M2 receptor antagonist | |||
| 0.082 | 0.064 | 0.082 | Histamine N-methyltransferase inhibitor | |||
| 0.028 | 0.01 | 0.028 | Beta 1 adrenoreceptor agonist | |||
| 0.185 | 0.168 | 0.185 | 12-Lipoxygenase inhibitor | |||
| 0.026 | 0.01 | 0.026 | 5-Alpha-reductase 2 inhibitor | |||
| 0.025 | 0.009 | 0.025 | Imidazoline I1 receptor antagonist | |||
| 0.039 | 0.023 | 0.039 | Vanilloid 3 antagonist | |||
| 0.022 | 0.006 | 0.028 | Telomerase stimulant | 0.028 0.003 CID_54040250 | CID_54040250 | |
| 0.048 | 0.032 | 0.048 | Benzodiazepine antagonist | |||
| 0.1 | 0.085 | 0.1 | Nav1.5 sodium channel blocker | |||
| 0.033 | 0.018 | 0.033 | Cyclophilin A inhibitor | |||
| 0.039 | 0.024 | 0.039 | Retinoid X receptor antagonist | |||
| 0.044 | 0.029 | 0.044 | Glutamate (mGluR group III) antagonist | |||
| 0.019 | 0.004 | 0.019 | Thromboxane agonist | |||
| 0.031 | 0.017 | 0.031 | Potassium channel (Inward rectifier) 1 blocker | |||
| 0.035 | 0.021 | 0.035 | Free fatty acid receptor 1 antagonist | |||
| 0.05 | 0.036 | 0.05 | Alpha 1b adrenoreceptor agonist | |||
| 0.06 | 0.046 | 0.06 | Prostaglandin F2 alpha antagonist | |||
| 0.025 | 0.011 | 0.025 | Retinoic acid gamma receptor agonist | |||
| 0.102 | 0.088 | 0.102 | MAO inhibitor | |||
| 0.092 | 0.078 | 0.092 | Falcipain 3 inhibitor | |||
| 0.035 | 0.022 | 0.035 | Retinoid X alpha receptor antagonist | |||
| 0.023 | 0.009 | 0.023 | Factor IX inhibitor | |||
| 0.088 | 0.075 | 0.16 | Xanthine oxidase inhibitor | 0.16 0.031 CID_54040250 | CID_54040250 | |
| 0.024 | 0.011 | 0.024 | Somatostatin 3 antagonist | |||
| 0.023 | 0.01 | 0.023 | Retinoid X beta receptor antagonist | |||
| 0.02 | 0.008 | 0.02 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.016 | 0.004 | 0.016 | Immunosuppressant Cyclosporine-like | |||
| 0.019 | 0.007 | 0.019 | Vitamin D receptor agonist | 0.017 0.01 CID_54040250 | ||
| 0.086 | 0.075 | 0.086 | 5-Lipoxygenase inhibitor | |||
| 0.033 | 0.021 | 0.033 | ATP citrate lysase inhibitor | |||
| 0.035 | 0.023 | 0.035 | Calcitonin receptor agonist | |||
| 0.083 | 0.071 | 0.112 | ATPase (Vacuolar H+) inhibitor | 0.112 0.026 CID_54040250 | CID_54040250 | |
| 0.053 | 0.041 | 0.053 | Epithelial sodium channel blocker | |||
| 0.024 | 0.013 | 0.024 | Glutamate (mGluR1a) agonist | |||
| 0.025 | 0.013 | 0.025 | Alpha 1a adrenoreceptor agonist | |||
| 0.021 | 0.01 | 0.021 | 5-Alpha-reductase 1 inhibitor | |||
| 0.027 | 0.016 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.122 | 0.111 | 0.351 | Hemostatic | 0.351 0.011 CID_54040250 | CID_54040250 | |
| 0.036 | 0.026 | 0.036 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.137 | 0.126 | 0.137 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.019 | 0.008 | 0.019 | Tryptophan hydroxylase 1 inhibitor | |||
| 0.15 | 0.141 | 0.15 | Growth factor agonist | |||
| 0.05 | 0.041 | 0.05 | Toll-Like receptor 8 antagonist | |||
| 0.066 | 0.056 | 0.066 | Protein kinase C beta inhibitor | |||
| 0.026 | 0.017 | 0.026 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.038 | 0.029 | 0.038 | 5 Hydroxytryptamine 2B agonist | |||
| 0.017 | 0.009 | 0.017 | Thromboxane A2 agonist | |||
| 0.018 | 0.01 | 0.018 | Carbonic anhydrase X inhibitor | |||
| 0.018 | 0.01 | 0.018 | Carbonic anhydrase VIII inhibitor | |||
| 0.038 | 0.03 | 0.038 | Retinoic acid alpha receptor agonist | |||
| 0.021 | 0.013 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.033 | 0.026 | 0.033 | Somatostatin 5 agonist | |||
| 0.042 | 0.035 | 0.042 | Purinergic P2Y antagonist | |||
| 0.061 | 0.053 | 0.061 | Transcription factor RelA inhibitor | |||
| 0.012 | 0.005 | 0.012 | CD80 antagonist | |||
| 0.012 | 0.006 | 0.012 | Imidazoline I2 receptor antagonist | |||
| 0.041 | 0.035 | 0.041 | Sphingosine 1-phosphate receptor agonist | |||
| 0.022 | 0.016 | 0.022 | Isoleucine-tRNA ligase inhibitor | |||
| 0.041 | 0.034 | 0.041 | GABA B receptor antagonist | |||
| 0.038 | 0.031 | 0.041 | Toll-Like receptor 2 agonist | 0.041 0.029 CID_54040250 | CID_54040250 | |
| 0.02 | 0.014 | 0.02 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.059 | 0.054 | 0.059 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.059 | 0.055 | 0.059 | Carbonic anhydrase V inhibitor | |||
| 0.042 | 0.038 | 0.042 | Thymidylate synthase inhibitor | |||
| 0.016 | 0.012 | 0.016 | Adenosine A2 receptor agonist | |||
| 0.041 | 0.037 | 0.041 | Dihydroorotase inhibitor | |||
| 0.111 | 0.107 | 0.111 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.071 | 0.067 | 0.071 | Acetylcholine nicotinic antagonist | |||
| 0.022 | 0.018 | 0.022 | Retinoic acid receptor agonist | |||
| 0.039 | 0.035 | 0.039 | Glutamate (mGluR group III) agonist | |||
| 0.053 | 0.049 | 0.053 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.052 0.05 CID_54040250 | ||
| 0.039 | 0.037 | 0.039 | Nerve growth factor antagonist | |||
| 0.025 | 0.022 | 0.025 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.04 | 0.038 | 0.04 | AICAR transformylase inhibitor | |||
| 0.037 | 0.035 | 0.037 | Oxytocin agonist | |||
| 0.016 | 0.014 | 0.016 | Nicotinic acid receptor 1 antagonist | |||
| 0.011 | 0.009 | 0.011 | Beta 3 adrenoreceptor agonist | |||
| 0.008 | 0.006 | 0.008 | Thyroid hormone beta agonist | |||
| 0.081 | 0.079 | 0.081 | MAO A inhibitor | |||
| 0.011 | 0.009 | 0.011 | Glutamate (mGluR6) agonist | |||
| 0.049 | 0.047 | 0.049 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.013 | 0.011 | 0.013 | Angiotensin AT1B receptor antagonist | |||
| 0.01 | 0.009 | 0.01 | Calcineurin inhibitor | |||
| 0.022 | 0.021 | 0.022 | Prostaglandin H2 antagonist | |||
| 0.017 | 0.016 | 0.017 | Estrogen-related receptor gamma agonist | |||
| 0.014 | 0.012 | 0.014 | Adenosine A2a receptor agonist | |||
| 0.043 | 0.041 | 0.043 | CC chemokine 4 receptor antagonist | |||
| 0.033 | 0.032 | 0.033 | Farnesoid X receptor agonist | |||
| 0.018 | 0.017 | 0.018 | Caspase 8 inhibitor | |||
| 0.012 | 0.011 | 0.012 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.1 | 0.099 | 0.1 | Estrogen antagonist | |||
| 0.067 | 0.068 | 0.282 | Antineoplastic antibiotic | 0.282 0.011 CID_54040250 | CID_54040250 | |
| 0.02 | 0.021 | 0.021 | Vitamin D receptor antagonist | 0.021 0.019 CID_54040250 | CID_54040250 | |
| 0.045 | 0.047 | 0.133 | Protein 50S ribosomal subunit inhibitor | 0.133 0.008 CID_54040250 | CID_54040250 | |
| 0.029 | 0.032 | 0.056 | Arginase inhibitor | 0.056 0.012 CID_54040250 | CID_54040250 | |
| 0.048 | 0.051 | 0.114 | Heparanase inhibitor | 0.114 0.003 CID_54040250 | CID_54040250 | |
| 0.129 | 0.136 | 0.501 | Hepatoprotectant | 0.501 0.007 CID_54040250 | CID_54040250 | |
| 0.007 | 0.015 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.007 CID_54040250 | CID_54040250 | |
| 0.051 | 0.064 | 0.072 | Lipocortins synthesis agonist | 0.072 0.02 CID_54040250 | CID_54040250 | |
| 0.044 | 0.057 | 0.052 | Factor III inhibitor | 0.052 0.029 CID_54040250 | CID_54040250 | |
| 0.02 | 0.035 | 0.046 | Squalene synthetase inhibitor | 0.046 0.016 CID_54040250 | CID_54040250 | |
| 0.028 | 0.045 | 0.084 | Antibiotic Aminoglycoside-like | 0.084 0.004 CID_54040250 | CID_54040250 | |
| 0.046 | 0.065 | 0.406 | Selectin antagonist | 0.406 0.003 CID_54040250 | CID_54040250 | |
| 0.075 | 0.095 | 0.177 | Uric acid excretion stimulant | 0.177 0.017 CID_54040250 | CID_54040250 | |
| 0.036 | 0.057 | 0.086 | Carbonic anhydrase XIV inhibitor | 0.086 0.015 CID_54040250 | CID_54040250 | |
| 0.183 | 0.206 | 0.493 | Apoptosis antagonist | 0.493 0.021 CID_54040250 | CID_54040250 | |
| 0.084 | 0.114 | 0.1 | Beta amyloid protein antagonist | 0.1 0.09 CID_54040250 | CID_54040250 | |
| 0.118 | 0.148 | 0.472 | Platelet adhesion inhibitor | 0.472 0.006 CID_54040250 | CID_54040250 | |
| 0.081 | 0.111 | 0.195 | DNA polymerase I inhibitor | 0.195 0.029 CID_54040250 | CID_54040250 | |
| 0.079 | 0.112 | 0.213 | AMP-activated protein kinase stimulant | 0.213 0.009 CID_54040250 | CID_54040250 | |
| 0.046 | 0.079 | 0.095 | Adenine nucleotide translocase inhibitor | 0.095 0.005 CID_54040250 | CID_54040250 | |
| 0.068 | 0.106 | 0.176 | Transcription factor NF kappa B stimulant | 0.176 0.012 CID_54040250 | CID_54040250 | |
| 0.029 | 0.083 | 0.055 | Microtubule stabilization | 0.055 0.021 CID_54040250 | CID_54040250 | |
| 0.002 | 0.057 | 0.016 | Antibiotic Macrolide-like | 0.016 0.009 CID_54040250 | CID_54040250 | |
| 0.01 | 0.066 | 0.023 | Corticosteroid-like | 0.023 0.012 CID_54040250 | CID_54040250 | |
| 0.022 | 0.098 | 0.057 | Aldose reductase inhibitor | 0.057 0.034 CID_54040250 | CID_54040250 | |
| 0.012 | 0.088 | 0.065 | Protein 30S ribosomal subunit inhibitor | 0.065 0.005 CID_54040250 | CID_54040250 | |
| 0.096 | 0.189 | 0.155 | DNA methyltransferase I inhibitor | 0.155 0.099 CID_54040250 | CID_54040250 | |
| 0.091 | 0.215 | 0.215 | DNA methylase inhibitor | 0.215 0.07 CID_54040250 | CID_54040250 | |
| 0.007 | 0.158 | 0.018 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.018 0.01 CID_54040250 | CID_54040250 | |
| 0.016 | 0.168 | 0.037 | Toll-Like receptor 4 agonist | 0.037 0.005 CID_54040250 | CID_54040250 | |
| 0.063 | 0.227 | 0.771 | Angiogenesis stimulant | 0.771 0.004 CID_54040250 | CID_54040250 | |
| 0.077 | 0.247 | 0.317 | NOS3 expression enhancer | 0.317 0.015 CID_54040250 | CID_54040250 | |
| 0.08 | 0.259 | 0.137 | Interleukin 6 antagonist | 0.137 0.112 CID_54040250 | CID_54040250 | |
| 0.051 | 0.235 | 0.309 | Thrombolytic | 0.309 0.022 CID_54040250 | CID_54040250 | |
| 0.114 | 0.317 | 0.569 | Immunomodulator | 0.569 0.015 CID_54040250 | CID_54040250 | |
| 0.023 | 0.249 | 0.056 | Transcription factor AP-1 inhibitor | 0.056 0.054 CID_54040250 | CID_54040250 | |
| 0.021 | 0.266 | 0.086 | Glucose-6-phosphate translocase inhibitor | 0.086 0.009 CID_54040250 | CID_54040250 | |
| 0.121 | 0.367 | 0.449 | Caspase 3 stimulant | 0.449 0.03 CID_54040250 | CID_54040250 | |
| 0.095 | 0.341 | 0.154 | CC chemokine 6 receptor antagonist | 0.154 0.017 CID_54040250 | CID_54040250 | |
| 0.022 | 0.275 | 0.11 | Protein-tyrosine phosphatase 1B inhibitor | 0.11 0.07 CID_54040250 | CID_54040250 | |
| 0.03 | 0.289 | 0.21 | Topoisomerase II inhibitor | 0.21 0.031 CID_54040250 | CID_54040250 | |
| 0.083 | 0.356 | 0.309 | Alpha-glucosidase inhibitor | 0.309 0.155 CID_54040250 | CID_54040250 | |
| 0.017 | 0.291 | 0.06 | Nitric oxide donor | 0.06 0.048 CID_54040250 | CID_54040250 | |
| 0.043 | 0.342 | 0.301 | Cell adhesion inhibitor | 0.301 0.01 CID_54040250 | CID_54040250 | |
| 0.006 | 0.327 | 0.021 | Motilin receptor agonist | 0.021 0.018 CID_54040250 | CID_54040250 | |
| 0.053 | 0.397 | 0.351 | Tumour necrosis factor alpha release inhibitor | 0.351 0.038 CID_54040250 | CID_54040250 | |
| 0.033 | 0.411 | 0.222 | Anticoagulant | 0.222 0.046 CID_54040250 | CID_54040250 | |
| 0.016 | 0.408 | 0.132 | Topoisomerase II alpha inhibitor | 0.132 0.027 CID_54040250 | CID_54040250 | |
| 0.028 | 0.423 | 0.086 | Thioredoxin inhibitor | 0.086 0.069 CID_54040250 | CID_54040250 | |
| 0.086 | 0.516 | 0.596 | Apoptosis agonist | 0.596 0.05 CID_54040250 | CID_54040250 | |
| 0.014 | 0.493 | 0.215 | Topoisomerase I inhibitor | 0.215 0.023 CID_54040250 | CID_54040250 | |
| 0.016 | 0.499 | 0.13 | Cell adhesion molecule inhibitor | 0.13 0.02 CID_54040250 | CID_54040250 | |
| 0.013 | 0.567 | 0.09 | DNA intercalator | 0.09 0.086 CID_54040250 | CID_54040250 | |
| 0.013 | 0.676 | 0.109 | Multidrug resistance-associated protein 1 inhibitor | 0.109 0.063 CID_54040250 | CID_54040250 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |